The global immunoprecipitation market size is expected to exhibit a solid 5.2% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). Immunoprecipitation is becoming increasingly important in the life sciences sector, leading to a growing demand for immunoprecipitation processes and objects. The market is expected to rise to a valuation of USD 562 million by 2023, according to the MRFR report.
The leading drivers and restraints affecting the global immunoprecipitation market are analyzed in detail in the report, giving readers a clear idea of what is affecting the market to the greatest degree. The leading players operating in the global immunoprecipitation market are also profiled in the report.
Various environmental factors have led to a growing prevalence of autoimmune disorders, while people are also more aware of autoimmune disorders than ever before. This has led to a growing demand for processes used to identify and cure autoimmune disorders.
Competitive Leader board:
Leading players in the global immunoprecipitation market include Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Merck KGaA, BioLegend Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology Inc., and Geno Technology Inc.
The global immunoprecipitation market has been segmented on the basis of type, product, end-user, and region.
The immunoprecipitation market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.
The market, by product type, has been segmented into kit, reagent, and others. The reagent segment has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.